[go: up one dir, main page]

CL2017001613A1 - Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados - Google Patents

Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados

Info

Publication number
CL2017001613A1
CL2017001613A1 CL2017001613A CL2017001613A CL2017001613A1 CL 2017001613 A1 CL2017001613 A1 CL 2017001613A1 CL 2017001613 A CL2017001613 A CL 2017001613A CL 2017001613 A CL2017001613 A CL 2017001613A CL 2017001613 A1 CL2017001613 A1 CL 2017001613A1
Authority
CL
Chile
Prior art keywords
composition
omega
peso
compositions
polyinsaturated
Prior art date
Application number
CL2017001613A
Other languages
English (en)
Inventor
Guenter Knaup
Milan Latinovic
Michael Schwarm
Original Assignee
Evonik Degussa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344990&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017001613(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evonik Degussa Gmbh filed Critical Evonik Degussa Gmbh
Publication of CL2017001613A1 publication Critical patent/CL2017001613A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B5/00—Preserving by using additives, e.g. anti-oxidants
    • C11B5/0085—Substances of natural origin of unknown constitution, f.i. plant extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/18—Lipids
    • A23V2250/186—Fatty acids
    • A23V2250/1882—Polyunsaturated fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

<p>LA PRESENTE INVENCIÓN SE REFIERE A PROCESOS PARA AUMENTAR LA ESTABILIDAD DE COMPOSICIONES QUE COMPRENDEN ÁCIDOS GRASOS OMEGA-6 POLIINSATURADOS CONTRA LA OXIDACIÓN. LOS PROCESOS COMPRENDEN LAS SIGUIENTES ETAPAS: (I) PROPORCIONAR UNA COMPOSICIÓN DE PARTIDA QUE COMPRENDE AL MENOS UN COMPONENTE ÁCIDO GRASO OMEGA-6 POLIINSATURADO; (II) PROPORCIONAR UNA COMPOSICIÓN DE LISINA; (III) MEZCLAR SOLUCIONES ACUOSAS, ACUOSO-ALCOHÓLICAS O ALCOHÓLICAS DE COMPOSICIÓN DE PARTIDA Y COMPOSICIÓN DE LISINA, Y SOMETER POSTERIORMENTE LA MEZCLA RESULTANTE A CONDICIONES DE SECADO POR PULVERIZACIÓN, FORMANDO ASÍ UNA COMPOSICIÓN DE PRODUCTO SÓLIDO QUE COMPRENDE AL MENOS UNA SAL DE UN CATIÓN DERIVADO DE LISINA CON UN ANIÓN DERIVADO A PARTIR DE UN ÁCIDO GRASO OMEGA-6 POLIINSATURADO: LA COMPOSICIÓN DEL PRODUCTO QUE PRESENTA UN CONTENIDO DE DISOLVENTE SC SELECCIONADO ENTRE LOS SIGUIENTES: SC ?5% EN PESO, SC  ? 3% EN PESO, SC  ? 1% EN PESO, SC ? 0.5% EN PESO.  LAS COMPOSICIONES OBTENIBLES MEDIANTE TALES PROCESOS DE SECADO POR PULVERIZACIÓN Y EL USO DE TALES COMPOSICIONES PARA LA FABRICACIÓN DE PRODUCTOS ALIMENTICIOS, NUTRICIONALES Y FARMACÉUTICOS ESTÁN COMPRENDIDOS ADEMÁS POR LA PRESENTE INVENCIÓN.</p>
CL2017001613A 2014-12-23 2017-06-19 Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados CL2017001613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14199976 2014-12-23

Publications (1)

Publication Number Publication Date
CL2017001613A1 true CL2017001613A1 (es) 2018-01-12

Family

ID=52344990

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017001613A CL2017001613A1 (es) 2014-12-23 2017-06-19 Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados

Country Status (24)

Country Link
US (1) US20170367394A1 (es)
EP (1) EP3236783B1 (es)
JP (1) JP6714000B2 (es)
KR (1) KR20170094789A (es)
CN (1) CN107105693B (es)
AU (1) AU2015371457B2 (es)
BR (1) BR112017013445B1 (es)
CA (1) CA2969157C (es)
CL (1) CL2017001613A1 (es)
CO (1) CO2017005849A2 (es)
DK (1) DK3236783T3 (es)
ES (1) ES2776393T3 (es)
IL (1) IL252482B (es)
MX (1) MX391057B (es)
MY (1) MY190506A (es)
PE (1) PE20171082A1 (es)
PH (1) PH12017501144B1 (es)
PL (1) PL3236783T3 (es)
RU (1) RU2706072C2 (es)
SA (1) SA517381762B1 (es)
SG (1) SG11201704399RA (es)
TW (1) TWI693893B (es)
WO (1) WO2016102316A1 (es)
ZA (1) ZA201704821B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111032032B (zh) * 2017-08-15 2024-01-02 赢创运营有限公司 具有高活性成分含量的ω-3脂肪酸氨基酸盐的片剂
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
US20220280387A1 (en) * 2019-08-08 2022-09-08 Evonik Operations Gmbh Down streaming process for the production of polyunsaturated fatty acid salts
MX2022001568A (es) * 2019-08-08 2022-03-02 Evonik Operations Gmbh Procedimiento de preparacion de una forma de dosificacion solida y un lubricante.
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
EP4009960B1 (en) 2019-08-08 2025-06-04 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
US20220287345A1 (en) * 2019-08-08 2022-09-15 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
WO2021151199A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
US20230037453A1 (en) 2020-04-01 2023-02-09 Evonik Operations Gmbh Preparation for use as vasorelaxant
US20230149336A1 (en) 2020-04-01 2023-05-18 Evonik Operations Gmbh Preparation for use as antioxidant
CN111635306B (zh) * 2020-06-12 2022-09-27 上海海益环保科技有限公司 一种芥酸复合稳定剂及制备稳定芥酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264987B1 (it) * 1993-12-14 1996-10-17 Prospa Bv Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
KR20110053281A (ko) * 2002-11-22 2011-05-19 니폰스이산가부시키가이샤 산화 안정성이 향상된 이중결합을 가진 유기물을 함유하는 조성물
JP4870430B2 (ja) * 2003-06-20 2012-02-08 持田製薬株式会社 下肢静脈瘤予防・治療用組成物
US20080311255A1 (en) * 2005-02-02 2008-12-18 Dsm Ip Assets B.V. Powder Compositions
US20140199313A1 (en) * 2005-03-02 2014-07-17 Metanomics Gmbh Process for the Production of Fine Chemicals
PL2040682T3 (pl) * 2006-06-05 2018-01-31 Dsm Nutritional Products Ag Mikrokapsułki o ulepszonych otoczkach
US20080026109A1 (en) * 2006-06-29 2008-01-31 Martek Biosciences Corporation Sweetened Oil Compositions and Methods of Making
CA2704345C (en) * 2007-11-01 2016-07-26 Enzymotec Ltd. Lipid mixture for infant nutrition
CA2803558C (en) * 2010-06-30 2018-05-29 Mochida Pharmaceutical Co., Ltd. .omega.3 fatty acid compound preparation

Also Published As

Publication number Publication date
CA2969157C (en) 2024-05-28
JP6714000B2 (ja) 2020-06-24
SA517381762B1 (ar) 2020-10-27
CN107105693B (zh) 2021-04-02
MX391057B (es) 2025-03-21
CA2969157A1 (en) 2016-06-30
BR112017013445B1 (pt) 2021-11-23
CO2017005849A2 (es) 2017-09-20
US20170367394A1 (en) 2017-12-28
JP2018501790A (ja) 2018-01-25
DK3236783T3 (da) 2020-04-27
KR20170094789A (ko) 2017-08-21
ES2776393T3 (es) 2020-07-30
RU2706072C2 (ru) 2019-11-13
MY190506A (en) 2022-04-26
MX2017008274A (es) 2017-10-02
IL252482A0 (en) 2017-07-31
IL252482B (en) 2021-08-31
AU2015371457A1 (en) 2017-06-22
TWI693893B (zh) 2020-05-21
EP3236783B1 (en) 2020-02-05
BR112017013445A2 (pt) 2018-06-26
EP3236783A1 (en) 2017-11-01
CN107105693A (zh) 2017-08-29
PE20171082A1 (es) 2017-08-03
WO2016102316A1 (en) 2016-06-30
TW201639463A (zh) 2016-11-16
PH12017501144A1 (en) 2018-03-05
PL3236783T3 (pl) 2020-06-15
AU2015371457B2 (en) 2020-04-23
RU2017125963A (ru) 2019-01-24
RU2017125963A3 (es) 2019-06-18
NZ732380A (en) 2024-03-22
SG11201704399RA (en) 2017-07-28
ZA201704821B (en) 2019-06-26
PH12017501144B1 (en) 2024-02-21

Similar Documents

Publication Publication Date Title
CL2017001614A1 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-3 poliinsaturados
CL2017001613A1 (es) Proceso para aumentar la estabilidad de una composición que comprende ácidos grasos omega-6 poliinsaturados
CL2020002269A1 (es) Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433)
CL2018003178A1 (es) Composición farmacéutica
NZ747847A (en) Lipid compositions
AR106204A1 (es) Método para fabricar una confitura congelada con revestimiento bajo en sfa y producto obtenido
BR112018074009A2 (pt) método para preparar uma composição compreendendo sais de ácidos graxos ômega-3
WO2015171460A3 (en) Formulations of cyclophosphamide liquid concentrate
MX2016011290A (es) Composiciones de ester de colina de acido lipoico y metodos de uso.
CL2017000475A1 (es) Composición para formulación cosmética que consiste en una mezcla de hasta 3 componentes seleccionados de manteca de murumuru, manteca de ucuuba, aceite de nuez de brasil, aceite de maracuyá, manteca de copoazú, aceite de acai y aceite de andiroba y/o ésteres de los mismos; producto cosmético.
CL2016001375A1 (es) Composición, que comprende agente bioactivo (inmunógeno) dispersado en gotitas de aceite, polímero de recubrimiento entérico, un polímero mucoadhesivo, su método de preparación y uso para la administración oral de un agente bioactivo.
BR112017019177A2 (pt) emulsão, produto alimentício, formulação, uso de uma formulação, gotículas aquosas e processo
MX2016017131A (es) Composicion novedosa de un producto de confiteria.
WO2016137825A8 (en) Millicapsule formulations comprising polyunsaturated free fatty acids
BR112016028561A8 (pt) composição e forma de dosagem compreendendo um óleo marinho que compreende ácidos graxos, e, uso das mesmas
BR112018008588A2 (pt) composição, e, processo para preparar uma composição.
MX387178B (es) Preparaciones de vitaminas que contienen galato de propilo.
MX2016012440A (es) Composicion de carbohidrato y proceso para la elaboracion de una composicion de carbohidrato.
PE20170250A1 (es) Composiciones estructuradas de grasa vegetal, proceso para obtener dicha composicion estructurada de grasas, uso de la composicion estructurada de grasas en la preparacion de una composicion cosmetica, composicion cosmetica y producto que comprende dicha composicion estructurada de grasas
PE20221451A1 (es) Producto alimenticio en polvo, semi terminado, basado en alimentos vegetales y un proceso para la produccion del mismo
EA201692398A1 (ru) Гомогенная композиция для перорального введения, содержащая омега-3 полиненасыщенные жирные кислоты и ресвератрол
BR112012026925A2 (pt) formulações dietéticas de liberação lenta.
CL2018000753A1 (es) Gel hidrófobo basado en vitamina e libre de productos de silicona para aplicación tópica
CL2017002828A1 (es) Composición para tratamiento de estrés oxidativo y enfermedad cardiovascular
MX2015002077A (es) Procedimiento para la obtencion de un colorante alimentario liquido con base en rizomas de la curcuma longa l.